Kronos Bio, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kronos Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.03M, a 67.8% decline year-over-year.
  • Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $17.1M, a 37.8% decline year-over-year.
  • Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25M, a 19.8% decline from 2022.
  • Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31.1M, a 18.8% increase from 2021.
  • Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $26.2M, a 598% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $25M -$6.16M -19.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $31.1M +$4.93M +18.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $26.2M +$22.5M +598% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $3.75M +$3.64M +3221% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $113K +$83K +277% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $30K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.